Literature DB >> 18469556

Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.

Be'eri Niego, Anita Horvath, Paul B Coughlin, Michael K Pugsley, Robert L Medcalf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18469556     DOI： 10.1097/MBC.0b013e3282f54568

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN： 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  4 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

Review 2.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies.

Authors:  Roberto Picetti; Haleema Shakur-Still; Robert L Medcalf; Joseph F Standing; Ian Roberts
Journal:  Blood Coagul Fibrinolysis       Date:  2019-01       Impact factor: 1.276

4.  A novel ex vivo approach for measuring plasminogen activation upon established plasma clots.

Authors:  Jason S Palazzolo; Robert L Medcalf; Christoph E Hagemeyer; Be'eri Niego
Journal:  Res Pract Thromb Haemost       Date:  2022-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.